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Introduction: Embryonic stem (ES) cells are considered a potentially advantageous source of hepatocytes for both
transplantation and the development of bioartificial livers. However, the efficient large-scale generation of functional
hepatocytes from ES cells remains a major challenge, especially for those methods compatible with clinical
applications.
Methods: In this study, we investigated whether a large number of functional hepatocytes can be differentiated
from mouse ES (mES) cells using a simulated microgravity bioreactor. mES cells were cultured in a rotating
bioreactor in the presence of exogenous growth factors and hormones to form embryoid bodies (EBs), which then
differentiated into hepatocytes.
Results: During the rotating culture, most of the EB-derived cells gradually showed the histologic characteristics of
normal hepatocytes. More specifically, the expression of hepatic genes and proteins was detected at a higher level
in the differentiated cells from the bioreactor culture than in cells from a static culture. On further growing, the
EBs on tissue-culture plates, most of the EB-derived cells were found to display the morphologic features of
hepatocytes, as well as albumin synthesis. In addition, the EB-derived cells grown in the rotating bioreactor
exhibited higher levels of liver-specific functions, such as glycogen storage, cytochrome P450 activity, low-density
lipoprotein, and indocyanine green uptake, than did differentiated cells grown in static culture. When the
EB-derived cells from day-14 EBs and the cells’ culture supernatant were injected into nude mice, the transplanted
cells were engrafted into the recipient livers.
Conclusions: Large quantities of high-quality hepatocytes can be generated from mES cells in a rotating bioreactor
via EB formation. This system may be useful in the large-scale generation of hepatocytes for both cell transplantation
and the development of bioartificial livers.* Correspondence: yingjiewang126@126.com; Yong-Jian.Geng@uth.tmc.edu
†Equal contributors
1Artificial Liver Lab., Southwest Hospital, Third Military Medical University,
Chongqing 400038, China
2University of Texas Health Science Center and Texas Heart Institute,
Houston, TX 77030, USA
Full list of author information is available at the end of the article
© 2013 Zhang et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Zhang et al. Stem Cell Research & Therapy 2013, 4:145 Page 2 of 12
http://stemcellres.com/content/4/6/145Introduction
The management of patients with acute liver failure
(ALF) is challenging. Emergency liver transplantation re-
mains the most successful treatment in many cases of
ALF. However, because of the shortage of available
donor organs, only 20% of patients with ALF receive a
transplant, and 80% die while on the waiting list [1]. In
the past decade, both hepatocyte transplantation and
bioartificial livers have been investigated as a “bridge” or
alternative to liver transplantation, which are promising
treatment options for ALF patients awaiting a donor
liver [2-4]. However, hepatocyte transplantation and the
development of bioartificial livers entail a large quantity
of high-quality hepatocytes, which also requires a donor
liver. Thus an urgent need exists for an alternative and
adequate supply of suitable hepatocytes for both hepato-
cyte transplantation and bioartificial livers [5].
Embryonic stem (ES) cells, pluripotent cells derived
from the inner cell mass of preimplantation blastocysts,
have the unique ability to give rise to all somatic cell lin-
eages [6,7]. In particular, the differentiation of hepato-
cytes or hepatocyte-like cells from ES cells in vitro and
in vivo has been reported [8-10]. Such ES cell-derived
hepatocytes are anticipated to be a useful source of cells
for the treatment of liver diseases [11,12]. However,
none of the previous work with ES cells has achieved
the efficient differentiation of ES cells into hepatocyte-
like cells by using a protocol that meets the demands of
the clinical applications.
Recent studies have demonstrated that a rotating cell-
culture system (RCCS) can enhance the efficiency of hu-
man embryoid body (EB) formation and differentiation
[13,14]. The rotating bioreactor of the RCCS creates a
simulated microgravity, allowing the ES cells to grow
and differentiate in three-dimensional (3D) culture [15].
Hepatocytes in 3D multicellular aggregates or spheroids
have been shown to maintain their morphology and ul-
trastructural characteristics, resulting in higher degrees
of liver-specific functions [16,17]. Previous reports have
also revealed that mouse ES (mES) cells differentiate
into hepatocytes via embryoid body (EB) formation
in vitro [18,19].
In our prior study, we demonstrated that the growth
and differentiation of ES cells in a biodegradable poly-
mer scaffold within a rotating microgravity bioreactor
yields organized functional hepatocytes that can be used
in research on bioartificial livers and engineered liver
tissue [20]. Therefore, we hypothesized that a rotating
bioreactor could be used for the efficient large-scale dif-
ferentiation of ES cells into hepatocytes, which may fur-
ther serve as an ideal source of cells for both hepatocyte
transplantation and the creation of bioartificial livers.
Here, to validate this hypothesis, we investigated whe-
ther mES cells can be induced to differentiate efficientlyinto cells with the morphologic, biologic, and functional
characteristics of hepatocytes by using a rotating bio-
reactor and exogenous growth factors and hormones.
Materials and methods
ES cells culture
mES cells (CCE line) (Stemcell Technologies, Vancouver,
BC, Canada) were cultured on gelatin-coated dishes
in Iscove modified Dulbecco medium (IMDM) (Gibco,
Grand Island, NY, USA) containing 15% fetal bovine
serum (FBS) (Gibco), 0.1 mM nonessential amino acids,
2 mM L-glutamine, 0.1 mM monothioglycerol, 50 U/ml
penicillin, 50 μg/ml streptomycin, and 1,000 U/ml re-
combinant mouse leukemia inhibitory factor (Chemicon
International, Temecula, CA, USA).
EB formation and hepatic differentiation in a rotating
bioreactor
mES cells were dissociated by using trypsin and seeded
into a rotating bioreactor (Synthecon Inc., Houston, TX,
USA) at a concentration of 1 × 106 cells/ml IMDM,
which was supplemented with 10-7M dexamethasone
(Sigma, St. Louis, MO, USA), 1% dimethyl sulfoxide
(DMSO) (Sigma), 20 ng/ml recombinant mouse hepato-
cyte growth factor (HGF) (R&D Systems, Minneapolis,
MN, USA), 10 ng/ml recombinant human fibroblast
growth factor-4 (FGF4) (Sigma), ITS (10 μg/ml insulin,
5 μg/ml transferrin, 5 ng/ml selenium) (Gibco), 15%
FBS, 0.1 mM nonessential amino acids, 2 mM L-glutam-
ine, 0.1 mM monothioglycerol, 50 U/ml penicillin, and
50 μg/ml streptomycin. The configuration of RCCS con-
sists of four 50-ml-capacity bioreactors. The rotating
bioreactor was set to rotate at a speed of 25 rpm at 37°C
and with a humidified atmosphere containing 5% CO2,
simulating microgravity to encourage cell 3D growth
and differentiation. Every 3 to 4 days, 70% to 80% of the
culture medium was replaced with fresh medium. In
total, the culture duration was 21 days. mES cells were
also differentiated by using the aforementioned exoge-
nous growth factors and hormones in a culture plate, a
two-dimensional culture (2D), as a control.
Visualization of cell growth and tissue processing
At various time points, EBs were removed from the ro-
tating bioreactor and placed into six-well plates, and ob-
served by using a stereomicroscope (SZX12; Olympus,
Tokyo, Japan). Subsequently, the EBs were cultured and
grown in six-well plates in the same differentiation me-
dium described earlier and observed by using a phase-
contrast microscope (IX50; Olympus). For histologic
examination, the EBs were fixed for 24 hours in 10%
neutral buffered formalin, routinely processed, and em-
bedded in paraffin. Serial sections (4 μm) were then cut
and stained with hematoxylin and eosin (H&E).
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The total RNA was extracted by using an RNeasy Mini
Kit (Qiagen, Valencia, CA, USA) and treated with RNase-
free DNase (Qiagen). A reverse transcriptase-polymerase
chain reaction (RT-PCR) was performed by using a
Qiagen OneStep RT-PCR Kit with 10 U RNase inhibi-
tor (Invitrogen, Carlsbad, CA, USA) and 20 ng of RNA,
according to the manufacturer’s instructions. The PCR
primers and the length of the amplified products were as
follows: albumin (ALB) (5′-GCT ACG GCA CAG TGC
TTG-3′, 5′-CAG GAT TGC AGA CAG ATA GT-3′;
55°C; 35 cycles; 260 bp); α-fetoprotein (AFP) (5′-TCG
TAT TCC AAC AGG AGG-3′, 5′-AGG CTT TTG CTT
CAC CAG-3′; 55°C; 35 cycles; 182 bp); tyrosine amino-
transferase (TAT) (5′-ACC TTC AAT CCC ATC CGA-
3′, 5′-TCC CGA CTG GATAGG TAG-3′; 58°C; 35 cycles;
206 bp); glucose-6-phosphatase (G6P) (5′-CAG GAC
TGG TTC ATC CTT-3′, 5′-GTT GCT GTA GTA GTC
GGT-3′; 58°C; 35 cycles; 210 bp); transthyretin (TTR) (5′-
CTC ACC ACA GAT GAG AAG-3′, 5′-GGC TGA GTC
TCT CAA TTC-3′; 50°C; 35 cycles; 226 bp); and beta-
actin (5′-TTC CTT CTT GGG TAT GGA AT-3′, 5′-
GAG CAA TGA TCT TGA TCT TC-3′; 55°C; 35 cycles;
200 bp). The PCR products were separated by electro-
phoresis on 1.2% agarose gels and stained with ethidium
bromide. Beta-actin was used as an endogenous control.
Western blot (WB) analysis
The protein concentration of the EBs lysates was mea-
sured by using a Bio-Rad Protein Assay Kit (Bio-Rad,
Hercules, CA, USA). Approximately 20 μg of protein
from each supernatant was subjected to 4% to 15%
Tris–HCl gel electrophoresis (Bio-Rad) and then trans-
ferred onto a nitrocellulose membrane (Pierce, Rockford,
IL, USA). The membranes were blocked in 2.5% nonfat
milk in phosphate-buffered saline (PBS), followed by incu-
bation with a goat anti-mouse ALB antibody (1:10,000)
(MP Biomedicals, Aurora, OH, USA), a monoclonal anti-
human/mouse AFP antibody (1:1,000) (R&D Systems), or
a monoclonal anti-mouse cytokeratin 18 (CK-18) antibody
(1:2,500) (PROGEN Biotechnik, Heidelberg, Germany).
The blots were then incubated with a horseradish pero-
xidase (HRP)-conjugated donkey anti-goat IgG or goat
anti-mouse IgG secondary antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA). The protein bands were vi-
sualized by using enhanced chemiluminescence (Pierce),
and images were captured by using medical x-ray film.
Immunofluorescence
After deparaffinization and rehydration, the sections of
the day-14 EBs were heated in a microwave at 100°C for
5 minutes in 10 mM sodium citrate for antigen retrieval,
followed by blocking with 2% nonfat milk and 1% bovine
serum albumin (BSA) in PBS for 45 minutes at roomtemperature. The slides were incubated with a goat anti-
mouse ALB antibody (1:100) (Bethyl, Montgomery, TX,
USA), a monoclonal anti-human/mouse AFP antibody
(1:200) (R&D Systems), or a monoclonal against mouse
CK18 antibody (1:500) (Progen Biotechnik) overnight at
4°C. The slides were then treated with biotinylated anti-
mouse/rabbit IgG (Dako, Carpinteria, CA, USA) or bio-
tinylated anti-goat IgG (Dako) for 60 minutes and
followed by labeling with Texas Red-conjugated strepta-
vidin (Jackson ImmunoResearch, West Grove, PA, USA)
and DAPI (Sigma) nuclear staining. Immunofluorescence
was examined with fluorescence microscopy.
For the immunocytochemistry analysis, day-14 EBs
were plated on chamber slides and cultured for 5 days.
Next, the EB-derived cells were fixed in 4% paraformal-
dehyde in PBS for 20 minutes at 4°C and permeabilized
by using 0.1% Triton X-100 for 15 minutes. After block-
ing with a blocking solution, the cells were incubated
with primary antibody, as described for the immunohis-
tochemistry experiments, for 45 minutes at room tem-
perature. The appropriate secondary antibody and Texas
Red-conjugated streptavidin were then applied as des-
cribed earlier.
ALB product of cultured EBs
At days 7, 14, and 21 of the rotating culture, EBs were
seeded in 12-well plates at approximately 50 EBs/well
and incubated with fresh medium for 72 hours in 5%
CO2 at 37°C. The amount of ALB secreted into the
medium was quantified by using a mouse ALB ELISA
quantitation kit (Bethyl) under the conditions recom-
mended by the manufacturer.
Cytochrome P450 activity assay
During the rotating culture, EBs were removed from the
bioreactor at days 7, 14, and 21 and incubated with
10 μM pentoxyresorufin (Sigma) for 60 minutes at 37°C.
The red fluorescence from the resorufin in the EB-derived
cells, which was produced from the O-dealkylation of pen-
toxyresorufin by cytochrome P450, was visualized by con-
focal laser scanning microscopy (CLSM) (IX 71, Olympus)
[21]. The EBs were then immediately dissociated with
trypsin, fixed in 4% paraformaldehyde in PBS, and ana-
lyzed by flow cytometry (BD Biosciences, Franklin Lakes,
NJ, USA). Additionally, EBs were seeded and statically
cultured in six-well plates for 4 days, and the resultant
EB-derived cells were also incubated with pentoxyresoru-
fin and examined by CLSM [22].
Uptake of low-density lipoprotein (LDL)
EBs from day 7, 14, and 21 were incubated with 20 μg/ml
DiI-Ac-LDL (Biomedical Technologies, Stoughton, MA,
USA) for 4 hours at 37°C. The incorporation of the
fluorochrome-labeled LDL into the EB-derived cells was
Zhang et al. Stem Cell Research & Therapy 2013, 4:145 Page 4 of 12
http://stemcellres.com/content/4/6/145visualized by CLSM. The flow-cytometric analysis [23]
and CLSM observation of the DiI-Ac-LDL uptake by
the EB-derived cells were performed in a similar man-
ner to the assays described earlier for cytochrome P450
activity.
Periodic acid-Schiff (PAS) staining
PAS staining for intracellular glycogen was performed
for 72 hours on both EBs sections and the EBs cultured
in six-well plates by using a PAS staining kit (American
Master Tech Scientific, Lodi, CA, USA) [24].
Indocyanine green (ICG) uptake
Rotating-culture EBs were removed from the bioreactor
each week and further cultured in six-well plates for
72 hours. These EBs were then incubated in DMEM con-
taining 0.1% ICG (Sigma) and 10% FBS for 30 minutes at
37°C. After rinsing 3 times with PBS, the cellular uptake
of ICG was examined by both a stereomicroscopy and
phase-contrast microscopy [25,26].
Injection of EB-derived cells and culture supernatant
This study was approved by the Research Ethics Com-
mittee of the Southwest Hospital and Third Military
Medical University. After 14 days of culture, the EBs
were dissociated by using trypsin. These isolated cells
were incubated with DiI-Cell-labeling Solution (Molecu-
lar Probes, Eugene, OR, USA) for 15 minutes at 37°C
and then washed 5 times in PBS. The washed cells were
resuspended in PBS at a concentration of 1 × 106 cells/ml,
and the resultant cell suspension (0.2 ml) was trans-
planted into the spleens of 6- to 8-week-old nude
mice under anesthesia. The cell-culture supernatant
from the same EBs samples (0.2 ml) was injected into
the spleens of nude mice as a control. Each expe-
rimental group consisted of six animals. One and
2 months after the cell transplantation and culture-
supernatant injection, the nude mice were killed, and
their organs, including the liver, spleen, lung, and kid-
ney, were removed. The presence of tumors in these
organs was macroscopically investigated. Samples of
tissues were fixed in formalin, stained with H&E, and
then microscopically confirmed. Other tissue samples
were placed into OCT compound, and frozen sections
10 μm) were prepared and observed by fluorescence
microscopy.
Statistical analysis
Statistical analyses were performed by using PRISM 5.01
(GraphPad Software). The data are presented as the
mean values ± SD of n determinations, as indicated
in the figure legends. ANOVA was used to calculate
the significance of the differences between the meanvalues. A P value of < 0.05 was considered statistically
significant.
Results
EB formation and hepatic differentiation
To form EBs and differentiate these cells into hepato-
cytes, we used a rotating bioreactor (Figure 1A) to pro-
duce a 3D cell-culture system. mES cells were cultured
in the simulated microgravity generated from the dy-
namic 3D system. When the mES cells were seeded at a
concentration of 1 × 106 cells/ml and rotated in the bio-
reactor at a speed of 25 rpm, cell aggregates were ob-
served after 12 to 24 hours, and these aggregates became
typical EBs within 1 week (Figure 1B). To investigate the
cell number of EBs cultured in the bioreactor at day 21,
EBs was dissociated by trypsin and counted by using
a hemocytometer. The total number of cells harvested
from every bioreactor was 3.2 ± 1.1 × 109 at 21 days of
culture.
Examination of the EBs under a stereomicroscopy re-
vealed relatively homogeneous cell aggregates at day 7,
with a few cystic EBs present (Figure 1C). Extensive cell
clumps appeared after 2 to 3 weeks of suspension-
culture. H&E staining clearly revealed the differentiation
of the mES cells into cells with hepatocyte-like cells mor-
phology. These cells exhibited polyhedral contours, large
nuclei, and cordlike arrangement within the EBs at days
14 and 21 (Figure 1E, F), but not at day 7 (Figure 1D).
Further to confirm the hepatic differentiation of the
ES cells in the EBs, we seeded the EBs in six-well plates
and cultured the cells in the same differentiation me-
dium (Figure 1G). Morphologically distinct cell types
were observed in subculture. In particular, many of the
day-21 EB-derived cells were characterized by a uniform
pyramidal shape, large round nuclei, and dark granular
deposits within the cytoplasm after 3 days (Figure 1H)
and 5 days (Figure 1I) of culture, consistent with our
histologic observations.
Hepatic marker expression
The ES cells were evaluated for the expression of hepa-
tic-specific markers by using RT-PCR and WB analysis
before and after differentiation. The steady-state levels
of the ALB, AFP, TAT, G6P, and TTR mRNAs were de-
termined in the mES cells and differentiating EBs every
7 days by RT-PCR. All of the mRNAs were detected in the
EBs at day 7 and were maintained or increased up to day
21 of culture. Undifferentiated mES cells did not express
ALB, AFP, TAT, or G6P mRNA, but TTR mRNA was de-
tected (Figure 2A). In contrast to the differentiated mES
cells grown in culture plates with the same exogenous
growth factors and hormones, the EB cells cultured in
the rotating bioreactor exhibited increased expression of
hepatic-specific genes (Figure 2B). The day-1 EB-derived
Figure 2 Liver-specific gene expression of EBs. The expression of the liver-specific genes in the EBs was analyzed by RT-PCR (A, B) and WB
analysis (C, D). (A, C) The expression of the hepatic genes (A) and proteins (C) in the EBs at different time point of culture. (B, D) The expression
of the hepatic genes (B) and proteins (D) in the mES cells from the 3D culture and the differentiated mES cells from the 2D culture. P, positive
control.
Figure 1 Morphologic and histologic characteristics of EBs and EB-derived cells in the rotating bioreactor. (A) A rotating bioreactor was
used to create a 3D RCCS for mES cell culture. (B) A large number of homogeneous EBs was formed at day 7 in a rotating bioreactor with
exogenous growth factors and hormones. (C) Image of EBs by stereomicroscopy at day 14. (D-F) Images of EBs with H&E staining at day 7
(D), 14 (E), 21 (F). EB-derived cells from day 14 and day 21, but not day 7, exhibited polyhedral contours, large nuclei, and a cordlike arrangement.
(G-I) Images of EB-derived cells. When the day 21 EB-derived cells were seeded in six-well plates (G), most of the cells had a uniform pyramidal
shape after 3 days (H) and 5 days (I) of culture. Scale bar, 100 μm.
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tein bands corresponding to ALB, AFP, and CK-18 were
visible in the EBs at day 7. The band intensity reached a
maximum at day 14 (Figure 2C), and a significant diffe-
rence in ALB and AFP expression was observed between
the EB-derived cells cultured in the bioreactor and the
mES cells differentiated in the 2D culture (Figure 2D).Figure 3 Immunohistochemical and immunocytochemical staining of
was performed on sections of day-14 EBs by using anti-ALB, anti-AFP, and
(blue). (B) Immunocytochemical staining for ALB, AFP, and CK18 was perfo
5 days. Scale bar, 100 μm.Immunohistochemical and immunocytochemical staining
Further characterization of hepatic-specific protein ex-
pression was performed by using immunohistochemi-
cal and immunocytochemical staining. After 14 days
of culture in the rotating bioreactor, ALB, AFP, and
CK-18 were detected in paraffin sections of the EBs
(Figure 3A). Immunocytochemical staining revealed thatEBs from the rotating bioreactor. (A) Immunohistochemical staining
anti-CK18 antibodies (red). DAPI was also included for nuclear staining
rmed on the day 14 EB-derived cells cultured on chamber slides for
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markers of mature hepatocytes after 3 days of monolayer
subculture (Figure 3B), which is consistent with our im-
munohistochemical observations of the paraffin sections.
These results suggest that the microgravity of rotating bio-
reactor, together with exposure to exogenous growth fac-
tors, strongly promotes the differentiation of ES cells into
hepatocyte-like cells and the hepatic maturation of the dif-
ferentiated cells.
ALB production
ALB synthesis is a liver-specific parameter. Undifferen-
tiated mES cells and 2D differentiated mES cells did not
produce ALB at measurable levels (data not shown).
Figure 4 showed that ALB was produced by EB-derived
cells grown in a rotating bioreactor, after culture for
72 hours in 12-well plates. The day-14 and −21 EB-de-
rived cells produced higher levels of ALB than the
day-7 EB-derived cells (Figure 4).
Metabolic enzyme activity
Xenobiotic metabolism, which is mediated mostly by
cytochrome P450 enzymes, is a characteristic function of
hepatocytes. Cytochrome P450 activity can be assessed
by using the pentoxyresorufin-O-dealkylase (PROD)
assay, in which pentoxyresorufin, a nonfluorescent com-
pound, changed into resorufin, which emits red fluores-
cence. No PROD activity was observed in the aggregates
of the undifferentiated mES cells or in the day-7 EBs.
However, after 14 or 21 days in the rotating culture, the
EBs exhibited marked PROD activity (Figure 5A). A
significant level of fluorescence was also observed in
the cells cultured from the day-14 and day-21 EBs
(Figure 5B). In contrast, little fluorescence was noted
in the mES cells that were grown in the six-well platesFigure 4 ALB secretion from EB-derived cells. ALB production by
day 7, 14, and 21 EB-derived cells was quantified by using an ELISA
kit after 72 hours of monolayer culture. The results are expressed as
the means ± SD of six experiments. *P < 0.05.(Figure 5C). Flow-cytometric analysis confirmed that the
rotating culture resulted in a significant increase in the
number of PROD-positive cells in the EBs than among
the mES cells differentiated in 2D culture (Figure 5D-F).
These results suggest that because of the presence of en-
dogenous P450 enzymes, the EB-derived cells were able to
assume the metabolic functions of hepatocytes.
LDL uptake
The majority of LDL is metabolized in the liver. Thus,
LDL uptake is an important function of hepatocytes.
The ability of EB-derived cells to take up LDL was
assessed by DiI-Ac-LDL staining and flow cytometry. In-
creased staining was observed in the day-14 and day-21
EBs (Figure 6A). Similar results were also observed for
the staining of the statically cultured EB-derived cells
(Figure 6B). The differentiated mES cells were able to in-
corporate LDL after 14 days of culture in plates, but these
cells were low in quantity (Figure 6C). Flow-cytometric
analysis showed that the number of LDL-positive EB-
derived cells was greater than the number of LDL-positive
mES cells from the 2D culture (Figure 6D-F).
Glycogen and ICG staining
Glycogen production, also known as gluconeogenesis, is
another important function of hepatocytes. ICG is clinic-
ally used as a test substance to evaluate liver function, as
this dye is eliminated exclusively by mature hepatocytes.
To examine glycogen synthesis and storage in the differ-
entiated EB-derived cells, PAS staining was performed
on both EB sections and EBs that were cultured in six-
well plates. Stored glycogen was not observed in the
undifferentiated mES cells (Figure 7F) but was visualized
in the EBs after 7 days of culture in the rotating biore-
actor. The number of positive cells increased in a time-
dependent manner (Figure 7A-C). These findings were
confirmed by PAS staining of the EB-derived cells after
3 days of static subculture in plates (Figure 7D). Never-
theless, fewer PAS-positive cells were found in the differ-
entiated mES cell population from the 2D culture than
in the EB-derived cells after 3 days of static subculture
in plates (Figure 7E). Similar to the results of the PAS
staining, an increasing number of ICG-positive cells
were detected in the EBs between day 7 and day 21
(Figure 8A-C). ICG uptake was also clearly apparent
in the EB-derived cells after 3 days of static culture
(Figure 8D). In the control experiment, only a few ICG-
positive cells were observed among the differentiated mES
cells from the 2D culture (Figure 8E), and the undifferenti-
ated mES cells were negative for ICG staining (Figure 8F).
Transplantation of EB-derived cells
To assess whether the EB-derived cells were efficiently in-
tegrated into the livers of the recipient mice, we injected
Figure 5 Cytochrome P450 activity in EBs and EB-derived cells. (A-C) PROD activity (red) was detected in day-21 EBs (A), day-21 EB-derived
cells grown in monolayer culture (B), and mES cells differentiated in 2D culture (C) by CLSM. Scale bar, 100 μm. (D-F) Flow cytometric analysis
showed that the number of PROD-positive day-21 EB-derived cells (D) was higher than the number of differentiated mES cells from the 2D
culture (E). A significant difference in the number of PROD-positive cells was noted between the differentiated cell samples from the 3D and 2D
cultures (F). *P < 0.05.
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spleens of the nude mice (Figure 9A). Because the day-14
EBs not only strongly expressed hepatocyte-specific mar-
kers but also exhibited functions typical of hepatocytes,
the cells isolated from these EBs were used for the in-
jections. One month after transplantation, a large number
of EB-derived cells labeled with DiI were detected in the
recipient livers (Figure 9C), whereas no DiI-labeled EB-
derived cells were detected in the recipient spleens. The
results suggest that hepatocytes derived from EBs culturedFigure 6 LDL-uptake analysis of EBs and EB-derived cells. (A-C) CLSM
(red). Additionally, more day 21 EB-derived cells grown in monolayer cultur
culture (C). Scale bar, 100 μm. (D-F) Flow-cytometric analysis showed that
(D) was higher than the number of differentiated mES cells from 2D cultur
between the differentiated cell samples from the 3D and 2D cultures (F). *in the rotating bioreactor could be engrafted into the
livers of the recipient mice. One and two months after in-
jection, no tumors, such as teratomas, were observed in
the organs of the recipient mice (Figure 9B). We then
injected the cell-culture supernatant from the day-14 EBs
into nude mice but again did not find tumors in the or-
gans of the mice 2 months after injection. Although these
results indicate that hepatocytes or other cells originating
from ES cells grown in a rotating bioreactor are safe and
effective for use in our transplantation conditions, furtherimages indicated that the day-21 EBs (A) could incorporate DiI-Ac-LDL
e incorporated DiI-Ac-LDL (B) than the mES cells differentiated in 2D
the number of LDL uptake-positive cells derived from day-21 EBs
e exhibiting LDL uptake (E). A significant difference in the LDL uptake
P < 0.05.
Figure 7 PAS staining of EBs and EB-derived cells. PAS staining, used to detect glycogen in the EB sections, showed that the number of
positive cells increased from day 7 (A) to day 14 (B) and day 21 (C). More PAS-positive cells were present among the day 21 EB-derived cells
grown in monolayer culture (D) than the differentiated mES cells from the 2D culture (E). In contrast, the undifferentiated mES cells were
negative for PAS staining (F). Scale bar, 50 μm.
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needed to address the long-term safety, efficacy, and the-
rapeutic potentials of hepatocytes derived from EBs in the
rotating bioreactor.
Discussion
Many hepatic differentiation protocols involve EB for-
mation from ES cells grown in static culture [25,27].
Similar to embryos, EBs contain an endoderm, ectoderm,
and mesoderm, which are important for the induction of
complex differentiation [28]. Several techniques, such as
the hanging-drop and conical-tube methods [29], have
been developed to facilitate EB generation. The stirred-
tank bioreactor and perfused 3D bioreactor have been ap-
plied for the hepatic differentiation of ES cells [30,31].Figure 8 Indocyanine green staining of EBs and EB-derived cells. A low
cells (A), whereas an increasing number of ICG-positive cells appeared at day
present among the day 21 EB-derived cells grown in monolayer culture (D) c
undifferentiated mES cells were negative for ICG staining (F). Scale bar, 50 μmHowever, none of the current methods is sufficiently
stable and controllable for the large-scale differentiation of
ES cells for practical applications. Here, we used a rotating
bioreactor to induce EB formation and hepatic differen-
tiation. Cell culture in a rotating bioreactor has been
shown to support the efficient, large-scale production of
transplantable cells for bone-tissue engineering and of
hematopoietic cells [32,33]. To the best of our knowledge,
although a few studies have examined the formation and
multiple-tissue or tissue-specific differentiation of EBs in a
RCCS [15,34,35], no one has reported the hepatic differen-
tiation of mES cells via EB formation in a rotating bioreac-
tor. In our previous study [20], the hepatic differentiation
of mES cells within the 3D condition of a rotating biore-
actor has been described, which is similar to the presentlevel of indocyanine green staining was found in the day 7 EB-derived
14 (B) and day 21 (C). Additionally, more ICG-positive cells were
ompared with the differentiated mES cells from the 2D culture (E). The
.
Figure 9 Transplantation of EB-derived cells. (A) Day 14 EB-derived cells labeled with DiI (red) were transplanted into the spleens of nude
mice under anesthesia. (B) No development of tumors, such as teratomas, was observed in the livers of the recipient mice 2 months after the cell
injection. (C) One month after transplantation, fluorescence from the EB-derived cells labeled with DiI (red) was detected in frozen sections of the
recipient livers. Scale bar, 200 μm.
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scaffolds, growth-factor-reduced Matrigel, and a rotating
bioreactor in our previous study. Scaffolds and Matrigel
provided a 3D environment for the cell growth, prolife-
ration, and differentiation of mES cells. Tissue mass with
functional hepatocytes was obtained from the rotating
bioreactor for bioartificial livers and engineered liver tis-
sue. In this study, however, the formation of EBs was
dependent on mES cell self-assembly. A native 3D micro-
environment with cell-cell and cell-matrix interactions
was recapitulated in EBs. A large number of EBs with
functional hepatocytes were prepared in the rotating bio-
reactor. This method is suitable to large-scale generation
of hepatocytes derived from ES cells for cell transplan-
tation and the development of bioartificial livers. There-
fore, our data indicate that the rotating bioreactor is an
effective tool to provide a native 3D microenvironment
for the large-scale production of hepatocytes derived from
ES cells.
Several studies demonstrated that the optimal speed
for EB formation is 15 to 20 rpm in the rotating bioreac-
tor [33,36]. To enhance the efficiency of EB formation,
we chose a slow rotational speed and a high cell concen-
tration, resulting in large numbers of homogeneous EBs
within 1 week. By culturing ES cells in suspension in this
dynamic and mild environment, which is characterized
by extremely low fluid shear stress and optimal nutrient
and gas exchange, our protocol for EB formation not
only avoids massive cellular damage but also controls
the extent of EB agglomeration, thus reducing large cen-
tral necrosis in EBs. More important, both histologic
and morphologic observations revealed that this setup is
more beneficial for the differentiation of ES cells into
hepatocytes than standard conditions.It has been previously shown that exogenous growth
factors and hormones play an important role in the dif-
ferentiation of ES cells into hepatocytes and in the ex-
pression of the hepatocyte phenotype [37]. However, it is
still unclear which growth factor, hormone, or combin-
ation of the two is critical for the hepatic differentiation
of ES cells. Additionally, the optimal timing for the use
of these factors and hormones to differentiate ES cells
into hepatocytes is not known. In the current study, we
found that the hepatic differentiation of ES cells in a ro-
tating bioreactor was more efficient with than without
the presence of HGF, FGF4, dexamethasone, DMSO,
and ITS. More specifically, the early use of medium con-
taining these factors resulted in the efficient differen-
tiation of ES cells into hepatocytes, as determined by
morphologic analysis (data not shown).
In this study, we investigated the expression of TTR,
AFP, ALB, G6P, and TAT at the mRNA level. Among
these genes, TTR is a marker of endodermal differenti-
ation, AFP represents endodermal differentiation as well
as the early differentiation of fetal hepatocytes [38], ALB
appears in early fetal hepatocytes and reaches a maximal
level in adult hepatocytes [38], G6P is predominantly
expressed in hepatocytes in the late gestational and pe-
rinatal stages [39], and TAT is an excellent enzymatic
marker for perinatal or postnatal hepatocyte-specific dif-
ferentiation and represents an important function of the
liver [40]. In general, the expression of these specific
genes in cells derived from EBs is characteristic of differ-
entiated hepatocyte-like cells, although a proportion of
these genes is also expressed in the yolk sac and other
cells. The expression of such genes in EBs differentiating
in the presence of growth factors parallels the expression
observed in the embryonic liver in vivo. However, in our
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http://stemcellres.com/content/4/6/145tests, the mRNAs of TTR, AFP, ALB, G6P, and TAT
were expressed by day 7, and the expression of most of
the genes, such as ALB, G6P, and TAT, was noticeable
earlier than in previous reports [27,41]. The level expres-
sion of these genes was higher in the EB-derived cells
cultured in the bioreactor than the mES cells differenti-
ated in the 2D culture. Because the expression of the
ALB, AFP, and CK18 proteins was also detected in the
day-7 EBs by WB analysis, and based on our immuno-
staining results, we believe that growth of ES cells in a
rotating bioreactor supplemented with exogenous growth
factors not only strongly promotes differentiation into
hepatocyte-like cells but also enhances cell maturation.
The assay for ALB synthesis is well known as a rela-
tively specific test for the presence and activity of hepa-
tocytes during the hepatic differentiation of stem cells
[23,25]. We examined the ALB synthesis of mES cell-
derived EBs to confirm the differentiation of the ES cells
into functional hepatocytes. However, we failed to detect
ALB directly at measurable levels during the rotating
bioreactor culture period. As the probable reason for
this issue was the relatively low cell concentration in the
bioreactor, we removed the EBs from the bioreactor and
seeded them in 12-well plates at a concentration of ap-
proximately 50 EBs/well. After incubation with fresh
medium for 72 hours, these EBs secreted ALB into the
culture medium. The ability of the EBs to synthesize
ALB at days 14 and 21 was approximately sixfold to
eightfold higher than at day 7, confirming the hepatic
differentiation of the EBs.
Because normal hepatocytes possess many complex
functions, in addition to our ALB analysis, we used
other independent functional assays to verify further
the hepatocyte-like attributes of the differentiated ES
cells. Four functional tests were performed on both the
EBs from the rotating culture and the EB-derived cells
from the static culture more precisely to characterize the
hepatic functions of the differentiated cells. Our data dem-
onstrate that the EB-derived cells possessed cytochrome
P450 activity, stored glycogen, and took up ICG and LDL,
which were higher than that of cells derived from 2D
culture. Together, all of these results strongly suggest
that the cells differentiated in the rotating bioreactor,
along with growth factors and hormones, were func-
tional hepatocytes.
Conclusion
The use of a rotating bioreactor for the differentiation of
functional hepatocytes from ES cells, as reported in this
study, has two advantages. First, the hepatic differenti-
ation of ES cells in a rotating bioreactor is more effective
than in traditional 2D culture. Second, large quantities
of differentiated cells can be generated by using this
technique. In the present study, most of the differentiatedcells exhibited the complex functions of mature hepato-
cytes and the 3D characteristics of multicellular aggre-
gates, conforming to the requirements of high-quality,
high-density hepatocyte cultures for both hepatocyte
transplantation and the seeding of bioartificial liver de-
vices. Further research is needed to investigate the thera-
peutic potential of the differentiated cells grown under
these conditions and to optimize the protocol for the dif-
ferentiation of the EBs to avoid necrosis.
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